IL-6/JAK/STAT3 signaling in breast cancer metastasis: biology and treatment
SG Manore, DL Doheny, GL Wong, HW Lo - Frontiers in oncology, 2022 - frontiersin.org
Breast cancer is the most commonly diagnosed cancer in women. Metastasis is the primary
cause of mortality for breast cancer patients. Multiple mechanisms underlie breast cancer …
cause of mortality for breast cancer patients. Multiple mechanisms underlie breast cancer …
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …
M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges
GL Wong, SG Manore, DL Doheny, HW Lo - Seminars in cancer biology, 2022 - Elsevier
Breast cancer is the most commonly diagnosed cancer and second-leading cause of cancer
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …
Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors
YH Dinakar, H Kumar, SL Mudavath, R Jain, R Ajmeer… - Life Sciences, 2022 - Elsevier
Introduction Breast cancer (BC) accounts for the majority of cancers among the female
population. Anomalous activation of various signaling pathways has become an issue of …
population. Anomalous activation of various signaling pathways has become an issue of …
STAT3 signaling in breast cancer: multicellular actions and therapeutic potential
Simple Summary Many signaling pathways are overactive in breast cancer, and among
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …
c-Kit induces migration of triple-negative breast cancer cells and is a promising target for tyrosine kinase inhibitor treatment
JA López-Mejía, LF Tallabs-Utrilla… - International Journal of …, 2022 - mdpi.com
Triple-negative breast cancer (TNBC) is associated with a poor prognosis and the absence
of targeted therapy. c-Kit, a receptor tyrosine kinase (RTK), is considered a molecular target …
of targeted therapy. c-Kit, a receptor tyrosine kinase (RTK), is considered a molecular target …
[HTML][HTML] An in vitro investigation of the apoptosis-inducing activity of corosolic acid in breast cancer cells
SA Jasim, OZ Khalaf, SH Alshahrani… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Objective (s): Breast cancer is the most prevalent cancer among females with different
molecular subtypes. Corosolic acid is a pentacyclic triterpenoid with anti-cancer properties …
molecular subtypes. Corosolic acid is a pentacyclic triterpenoid with anti-cancer properties …
An update on investigational therapies that target STAT3 for the treatment of cancer
M Santoni, F Miccini, A Cimadamore… - Expert opinion on …, 2021 - Taylor & Francis
Introduction Signal transducer and activator of transcription 3 (STAT3) is involved in cancer
initiation and resistance to chemo-radiation therapies and targeted agents. The role of …
initiation and resistance to chemo-radiation therapies and targeted agents. The role of …
Dual-responsive PEG–lipid polyester nanoparticles for siRNA and vaccine delivery elicit anti-cancer immune responses by modulating tumor microenvironment
Z Liu, L Zhao, Y Feng, Q Wang, N Dong, Y Zhang… - Biomaterials …, 2023 - pubs.rsc.org
Cancer vaccine-based immunotherapy has great potential; however, the vaccines have
been hindered by the immunosuppressive tumor microenvironment (TME). In this study, dual …
been hindered by the immunosuppressive tumor microenvironment (TME). In this study, dual …
High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients
E Morrow, K Pennel, P Hatthakarnkul, H Leslie… - Cancer …, 2023 - Wiley Online Library
Introduction Triple‐negative breast cancer (TNBC) patients have the poorest clinical
outcomes compared to other molecular subtypes of breast cancer. IL6/JAK/STAT3 signalling …
outcomes compared to other molecular subtypes of breast cancer. IL6/JAK/STAT3 signalling …